Join IC-OS
Certifications Events Resources Chapters Get Involved

Copyright International Cardio-Oncology Society, 2026. All Rights reserved.

Home > Resources > Search > Providers

Resources for Providers

VIEW:
Select Grid View
Select Grid View
Open Filters
Hide Filter PanesHide Filter Pane

VIEW:
Select Grid View
Select Grid View

Filter By:
refresh filtersRESET FILTERS

  • IC-OS Heart
    DOCUMENTEXPERT OPINIONJOURNAL
    Cardio-oncology: the Polish National Oncology Network model
    Publish Date April 11, 2026
    Publish Date CARDIO-ONCOLOGHY GUIDELINE, IC-OS AROUND THE WORLD, POLAND
  • IC-OS Heart
    EXPERT CONSENSUSEXPERT OPINIONJOURNAL
    2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging
    Publish Date November 18, 2025
    Publish Date IMAGING
  • IC-OS Heart
    DOCUMENTPDF
    HER2 Inhibitors and Breast Cancer
    Publish Date October 23, 2025
    Publish Date BREAST CANCER
  • WEBINAR RECORDINGS
    Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy
    Publish Date June 12, 2025
    Publish Date ANTHRACYCLINES, CARDIOTOXICITY, HEART FAILURE; VENTRICULAR DYSFUNCTION, IMAGING
  • EXPERT CONSENSUSWEBINAR RECORDINGS
    OPCI Cardio-Oncology Journal Club
    Publish Date May 15, 2025
  • IC-OS Heart
    E-PUB
    Addressing cardiovascular risks with a goal to prevent cardiovascular complications in patients undergoing antihormonal therapy for prostate cancer
    Publish Date March 29, 2025
    Publish Date ANDROGEN DEPRIVATION THERAPY, CARDIOVASCULAR DISEASE, HEART DISEASE, PROSTATE CANCER
  • IC-OS Heart
    WEBINAR RECORDINGS
    Israel Heart Society Periodic Meeting on Cardio-Oncology: 1/14/25 Cardio-Oncology Webinar
    Publish Date March 6, 2025
  • IC-OS Heart
    WEBINAR RECORDINGS
    Israel Heart Society Periodic Meeting on Cardio-Oncology: 11/19/24 Cardio-Oncology Webinar
    Publish Date March 6, 2025
  • WEBINAR RECORDINGS
    St. Francis Heart Center Cardio-Oncology Journal Club
    Publish Date February 24, 2025
  • IC-OS Heart
    PDF
    Cardio-Oncology Facts for Nurses
    Publish Date April 10, 2024
    Publish Date NURSING
  • IC-OS Heart
    RESOURCES
    Proceedings From the Global Cardio-Oncology Summit The Top 10 Priorities to Actualize for CardioOncology
    Publish Date March 28, 2024
  • IC-OS Heart
    RESOURCES
    Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
    Publish Date March 28, 2024
    Publish Date CLINICAL PRACTICE
  • IC-OS Heart
    #N/AMEMBER PUBLICATION
    Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY
  • IC-OS Heart
    EXPERT CONSENSUS
    Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement
    Publish Date March 28, 2024
    Publish Date AMYLOIDOSIS
  • IC-OS Heart
    GUIDELINES
    ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?
    Publish Date March 28, 2024
    Publish Date PHARMACY
  • IC-OS Heart
    RESOURCES
    Implementing a Cardiooncology Center of Excellence Nuts and Bolts
    Publish Date March 28, 2024
    Publish Date CLINICAL PRACTICE
  • IC-OS Heart
    RESOURCES
    Future steps in cardio‑oncology—a national multidisciplinary survey among healthcare professionals in the Netherlands
    Publish Date March 28, 2024
    Publish Date INTERNATIONAL PERSPECTIVES
  • IC-OS Heart
    RESOURCES
    Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience
    Publish Date March 28, 2024
    Publish Date CLINICAL PRACTICE
  • IC-OS Heart
    GUIDELINES
    Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
    Publish Date March 28, 2024
    Publish Date AMYLOIDOSIS
  • IC-OS Heart
    EXPERT CONSENSUS
    Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY
  • IC-OS Heart
    EXPERT CONSENSUS
    Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS)
    Publish Date March 28, 2024
    Publish Date IMAGING
  • IC-OS Heart
    EXPERT CONSENSUS
    Cardiovascular Manifestations From Therapeutic Radiation A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society
    Publish Date March 28, 2024
    Publish Date RADIATION
  • IC-OS Heart
    EXPERT CONSENSUS
    Cardio-Oncology Education and Training: JACC Council Perspectives
    Publish Date March 28, 2024
    Publish Date CLINCAL PRACTICE
  • IC-OS Heart
    GUIDELINES
    Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology
    Publish Date March 28, 2024
    Publish Date CLINCAL PRACTICE
  • IC-OS Heart
    EXPERT CONSENSUS
    Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty
    Publish Date March 28, 2024
    Publish Date CLINICAL PRACTICE
  • IC-OS Heart
    EXPERT CONSENSUS
    An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY
  • IC-OS Heart
    GUIDLEINES
    2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)”
    Publish Date March 28, 2024
  • IC-OS Heart
    RESOURCES
    Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio- Oncology Society
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY, HEART FAILURE
  • IC-OS Heart
    GUIDELINES
    Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel
    Publish Date March 24, 2024
    Publish Date CARDIAC DISEASE
  • IC-OS Heart
    GUIDELINES
    Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel
    Publish Date March 24, 2024
    Publish Date CARDIAC DISEASE
  • IC-OS Heart
    EXPERT CONSENSUS
    Seeing the Forest for the Trees: Recognizing Potential Amyloidosis
    Publish Date January 23, 2024
    Publish Date AMYLOIDOSIS, CANCER SURVIVORSHIP, PATIENT MANAGEMENT, PATIENT STORIES
  • IC-OS Heart
    VIDEO
    Cancer Survivor Stories: Kreena’s Story
    Publish Date August 14, 2023
    Publish Date BREAST CANCER, HEART FAILURE
  • IC-OS Heart
    RESOURCES
    Cardio-Oncology Stories: Sofia’s Story
    Publish Date June 30, 2023
    Publish Date CHILDHOOD CANCER, PEDIATRIC CANCER, PEDIATRICS
  • IC-OS Heart
    JOURNAL
    Cardiovascular disease and asymptomatic childhood cancer survivors: Current clinical practice
    Publish Date May 13, 2020
    Publish Date CHILDHOOD CANCER, PEDIATRIC CANCER, PEDIATRICS
  • IC-OS Heart
    JOURNAL
    The landscape of cardiovascular care in pediatric cancer patients and survivors: a survey by the ACC Pediatric Cardio- Oncology Work Group
    Publish Date October 23, 2019
    Publish Date CHILDHOOD CANCER, PEDIATRIC CANCER, PEDIATRICS
  • IC-OS Heart
    JOURNAL SUBMISSION
    Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
    Publish Date November 28, 2016
    Publish Date BREAST CANCER
  • IC-OS Heart
    JOURNAL SUBMISSION
    Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
    Publish Date June 1, 2016
    Publish Date BREAST CANCER
    • End of List

Get Certified

See All Certifications
A white doctor and a black doctor discuss the test results

Cardio-Oncology Knowledge

Go To Certification
See Certified Providers
A white doctor and a black doctor discuss the test results

Center of Excellence

Go To Certification
See Centers of Excellence
A map of the world
Chapters
See All Chapters

North America

Europe

Asia + Oceania

South America

Africa